Lantheus Holdings IPO Research Information

Lantheus Holdings IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on Lantheus Holdings, and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
Lantheus Holdings	LNTH - NASDAQ	$8.50-$10.50	$6.00	$6.12	10.83 million	6/25/2015
Underwriter(s): Credit Suisse, Jefferies, RBC Capital Markets, Wells Fargo Securities
Co-Manager(s): Baird
Industry: Health Care
Filing(s): Filed 2014-11-07 Terms Added 2015-06-16

Lantheus Holdings Quote & Chart - Click for current quote - LNTH

About Lantheus Holdings (adapted from Lantheus Holdings prospectus):
They are a global leader in developing, manufacturing, selling and distributing innovative diagnostic medical imaging agents and products that assist clinicians in the diagnosis of cardiovascular and other diseases.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as "LNTH" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.